Gastroenterology clinical trials recruiting in California

115 recruiting gastroenterology trials match in California. Showing 20.

• A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruiting

  Phase 1 · GlaxoSmithKline · Rialto, California

• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Janssen Research & Development, LLC · Los Angeles, California

• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsRecruiting

  Phase 2 · University of California, San Diego · La Jolla, California

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Anaheim, California

• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's DiseaseRecruiting

  Phase 4 · Connecticut Children's Medical Center · Los Angeles, California

• Capsule Microbiota Sampling in IBS/Functional Gastrointestinal DiseaseRecruiting

  N/A · Stanford University · Redwood City, California

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Anaheim, California

• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · AbbVie · Oakland, California

• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Phoenix, Arizona

• A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Rivus Pharmaceuticals, Inc. · Garden Grove, California

• Abbott Cephea Mitral Valve Disease RegistryRecruiting

  N/A · Abbott Medical Devices · Thousand Oaks, California

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Murrieta, California

• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisRecruiting

  Phase 4 · Bausch Health Americas, Inc. · Garden Grove, California

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting

  Phase 2 · Genentech, Inc. · Lancaster, California

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 2 · Eli Lilly and Company · Los Angeles, California

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Anaheim, California

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Canoga Park, California

• A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 3 · GlaxoSmithKline · Folsom, California

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Boehringer Ingelheim · Coronado, California

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Colorado Springs, Colorado

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.